A novel technology for the production of highly active therapeutic proteins.

Baumeister H, Goletz S. In: DrugPlus international 2004: Vol 03.

Voll funktionsfähige humane dendritische Zelllinie.

Baumeister H, Goletz S. In: Laborwelt 2005: Vol 6.

A Matter of Cell Line Development.

Baumeister H, Goletz S. In: European BioPharmaceutical Review 2010: Apr.

GlycoEngineering – a Technology for Production of Glycoproteins.

Baumeister H. In: BioTOPics 2004: Vol 24.

Opportunities with NEMOD & GLYCOTOPE.

Goletz S, Baumeister H. In: R&D FOCUS drugnews 2004: Vol 13

GlycoExpress: A novel expression system for the optimal glycosylation of biotherapeutics.

Baumeister H, Goletz S.: GlycoExpress. In: Speciality Chemicals Magazine 2005: Vol 25.

Novel Glycosylation Technologies for the Development of Biosimilars and Biobetters.

Baumeister H, Goletz S. In: Innovations In Pharmaceutical Technology 2009: Dec.

A novel human expression system for generating glycoprotein with higher activity, fully human glycosylation, and optimised sialylation.

Baumeister H, Schoeber U, Schlangstedt M, Stahn R, Goletz S. In: BioProcessing Journal 2005: Vol 4.